Explanations for the difference in rates of cardiovascular events in a trial of alendronate and romosozumab
Year: 2020
Type: editorial
Source: Osteoporosis International
Authors: S.R. Cummings, C. McCulloch
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3014210892
